BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37415628)

  • 21. Dosimetric Study Comparing 3D Conformal Radiotherapy (3D-CRT), Intensity Modulated Radiotherapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) in Hypofractionated One-Week Radiotherapy Regimen in Breast Cancer.
    Ahmad A; Das S; Kharade V; Gupta M; Pandey VP; K V A; Balasubramanian I; Pasricha RK
    Cureus; 2022 Nov; 14(11):e31860. PubMed ID: 36440297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results.
    De Rose F; Fogliata A; Franceschini D; Navarria P; Villa E; Iftode C; D'Agostino G; Cozzi L; Lobefalo F; Mancosu P; Tomatis S; Scorsetti M
    Radiat Oncol; 2016 Sep; 11(1):120. PubMed ID: 27639373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation pneumonitis in lung cancer treated with volumetric modulated arc therapy.
    Wu K; Xu X; Li X; Wang J; Zhu L; Chen X; Wang B; Zhang M; Xia B; Ma S
    J Thorac Dis; 2018 Dec; 10(12):6531-6539. PubMed ID: 30746197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage.
    Karpf D; Sakka M; Metzger M; Grabenbauer GG
    Radiat Oncol; 2019 Sep; 14(1):156. PubMed ID: 31477165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of conventional and advanced radiotherapy techniques for left-sided breast cancer after breast conserving surgery.
    Xie Y; Bourgeois D; Guo B; Zhang R
    Med Dosim; 2020 Winter; 45(4):e9-e16. PubMed ID: 32646715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
    Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
    Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VMAT partial-breast irradiation: acute toxicity of hypofractionated schedules of 30 Gy in five daily fractions.
    La Rocca E; Lozza L; D' Ippolito E; Dispinzieri M; Giandini C; Bonfantini F; Valdagni R; Folli S; Pignoli E; Di Cosimo S; De Santis MC
    Clin Transl Oncol; 2020 Oct; 22(10):1802-1808. PubMed ID: 32128672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Volumetric arc therapy: A viable option for right-sided breast with comprehensive regional nodal irradiation in conjunction with deep inspiration breath hold.
    Holt E; Mantel A; Cokelek M; Tacey M; Jassal S; Law M; Zantuck N; Yong C; Cheng M; Viotto A; Foroudi F; Chao M
    J Med Imaging Radiat Sci; 2021 Jun; 52(2):223-237. PubMed ID: 33771509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New fractionations in breast cancer: a dosimetric study of 3D-CRT versus VMAT.
    Piras A; Menna S; D'Aviero A; Marazzi F; Mazzini A; Cusumano D; Massaccesi M; Mattiucci GC; Daidone A; Valentini V; Boldrini L
    J Med Radiat Sci; 2022 Jun; 69(2):227-235. PubMed ID: 34551211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of abches and volumetric modulated arc therapy under deep inspiration breath-hold technique for patients with left-sided breast cancer: A retrospective observational study.
    Yeh TC; Chi MS; Chi KH; Hsu CH
    Medicine (Baltimore); 2019 Sep; 98(39):e17340. PubMed ID: 31574873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes.
    Popescu CC; Olivotto IA; Beckham WA; Ansbacher W; Zavgorodni S; Shaffer R; Wai ES; Otto K
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):287-95. PubMed ID: 19775832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume.
    Takeda A; Oku Y; Sanuki N; Eriguchi T; Aoki Y; Enomoto T; Kaneko T; Nishimura S; Kunieda E
    J Radiat Res; 2014 Sep; 55(5):988-95. PubMed ID: 24833770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.
    Kim TH; Cho KH; Pyo HR; Lee JS; Zo JI; Lee DH; Lee JM; Kim HY; Hwangbo B; Park SY; Kim JY; Shin KH; Kim DY
    Radiology; 2005 Apr; 235(1):208-15. PubMed ID: 15703313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Dosimetric Comparison of Volumetric Modulated Arc Therapy and Intensity Modulated Radiotherapy in Patients Treated with Post-Mastectomy Radiotherapy.
    Adeneye S; Akpochafor M; Adedewe N; Habeebu M; Jubril R; Adebayo A; Salako O; Joseph A; Ariyo I; Awhariado E; Lawal R
    Eur J Breast Health; 2023 Jan; 19(1):92-98. PubMed ID: 36605476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and outcomes of volumetric modulated arc therapy in the treatment of patients with inoperable lung cancer.
    Jin X; Lin B; Chen D; Li L; Han C; Zhou Y; Zheng X; Gong C; Chen M; Xie C
    J Cancer; 2019; 10(13):2868-2873. PubMed ID: 31281463
    [No Abstract]   [Full Text] [Related]  

  • 37. Post-Operative Accelerated-Hypofractionated Chemoradiation With Volumetric Modulated Arc Therapy and Simultaneous Integrated Boost in Glioblastoma: A Phase I Study (ISIDE-BT-2).
    Ferro M; Ferro M; Macchia G; Cilla S; Buwenge M; Re A; Romano C; Boccardi M; Picardi V; Cammelli S; Cucci E; Mignogna S; Di Lullo L; Valentini V; Morganti AG; Deodato F
    Front Oncol; 2020; 10():626400. PubMed ID: 33692944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost.
    Fiorentino A; Mazzola R; Naccarato S; Giaj-Levra N; Fersino S; Sicignano G; Tebano U; Ricchetti F; Ruggieri R; Alongi F
    Radiol Med; 2017 Jun; 122(6):464-471. PubMed ID: 28224401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Volumetric-modulated arc therapy for left-sided breast cancer and all regional nodes improves target volumes coverage and reduces treatment time and doses to the heart and left coronary artery, compared with a field-in-field technique.
    Tyran M; Mailleux H; Tallet A; Fau P; Gonzague L; Minsat M; Moureau-Zabotto L; Resbeut M
    J Radiat Res; 2015 Nov; 56(6):927-37. PubMed ID: 26386255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual partial arc volumetric-modulated arc therapy: The game changer for accelerated hypofractionated whole-breast radiotherapy with simultaneous integrated tumor cavity boost in early breast cancer - A comparative dosimetric study with single partial arc volumetric-modulated arc therapy.
    Mondal D; Julka PK; Sharma DN; Laviraj MA; Jana M; Kamal VK; Deo SVS; Guleria R; Rath GK
    J Cancer Res Ther; 2019; 15(5):1005-1010. PubMed ID: 31603102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.